ArchPrestige
liked and commented on
$Apple (AAPL.US)$ beware of a volume spike. if it happens, reversal incoming
1
3
ArchPrestige
liked
The CSRC said
1. Chinese regulators respect where the company decide to list at.
2. But China can order a company to dispose of its assets or businesses that jeopardizes national security.
3. Company listing overseas need to get approval and the company need to ensure data are protected and the listing won't affect national security.
https://www.channelnewsasia.com/business/china-proposes-tighter-rules-no-ban-offshore-listings-2400511
$UP Fintech (TIGR.US)$ $Futu Holdings Ltd (FUTU.US)$ $DiDi Global (Delisted) (DIDI.US)$ $Alibaba (BABA.US)$ $Tencent (TCEHY.US)$ $NIO Inc (NIO.US)$ $BYD Company ADR (BYDDY.US)$
1. Chinese regulators respect where the company decide to list at.
2. But China can order a company to dispose of its assets or businesses that jeopardizes national security.
3. Company listing overseas need to get approval and the company need to ensure data are protected and the listing won't affect national security.
https://www.channelnewsasia.com/business/china-proposes-tighter-rules-no-ban-offshore-listings-2400511
$UP Fintech (TIGR.US)$ $Futu Holdings Ltd (FUTU.US)$ $DiDi Global (Delisted) (DIDI.US)$ $Alibaba (BABA.US)$ $Tencent (TCEHY.US)$ $NIO Inc (NIO.US)$ $BYD Company ADR (BYDDY.US)$
26
12
ArchPrestige
liked and commented on
29
3
1
ArchPrestige
liked and commented on
$Apple (AAPL.US)$ that's right slowly going up
6
2
ArchPrestige
liked
$AMC Entertainment (AMC.US)$ - stock breaking out on Friday with a lot of momentum. Added some swing calls. Looking for break of $33 first PT
$Galera Therapeutics (GRTX.US)$ - last week Galera announced Primary Endpoint Met Statistical Significance In Corrected Topline Efficacy Data Of Phase 3 ROMAN Trial Of Avasopasem.
$Pfizer (PFE.US)$ - Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15. Can continue higher or break lower.
$Spruce Biosciences (SPRB.US)$ - Spruce Biosciences shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.
$Galera Therapeutics (GRTX.US)$ - last week Galera announced Primary Endpoint Met Statistical Significance In Corrected Topline Efficacy Data Of Phase 3 ROMAN Trial Of Avasopasem.
$Pfizer (PFE.US)$ - Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15. Can continue higher or break lower.
$Spruce Biosciences (SPRB.US)$ - Spruce Biosciences shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.
17
1
ArchPrestige
liked and commented on
3
1
ArchPrestige
liked and commented on
$Apple (AAPL.US)$ why aren't we uptrend?
8
2
ArchPrestige
liked
$Netflix (NFLX.US)$ There are naturally negative implications to price cuts, but India has always been a unique market requiring aggressive rate sheets. It may be the world's second-most populous country, but premium pricing is a challenge if you want to go mainstream. The reason why average revenue per user for $Disney (DIS.US)$ 's streaming service is lower now than it was a year ago is because a lot of its subscriber growth has come from its Disney+ Hotstar platform in India.
The timing of the Netflix price cut in India is also interesting. $Amazon (AMZN.US)$ had previously announced that the monthly price for its video streaming service was going to rise 39% to $2.35 on Tuesday. Netflix seemingly had the ideal opportunity to inch its price points higher, choosing instead to go the other way to grab market share.
Netflix will be fine, and don't go thinking that you'll be shaving 60% from your stateside subscription anytime soon. The five Netflix hikes for U.S. viewers since early 2014 for its most popular plan have amounted to an increase of between $1 to $2 a month in each case, but over time that's a 75% total increase.
There may very well come a time when the U.S. market will tire of feeding the meter at higher price points. No one has that kind of pricing flexibility. It just doesn't seem as if an isolated move in India would trigger price wars anywhere else in the Netflix playbook.
The timing of the Netflix price cut in India is also interesting. $Amazon (AMZN.US)$ had previously announced that the monthly price for its video streaming service was going to rise 39% to $2.35 on Tuesday. Netflix seemingly had the ideal opportunity to inch its price points higher, choosing instead to go the other way to grab market share.
Netflix will be fine, and don't go thinking that you'll be shaving 60% from your stateside subscription anytime soon. The five Netflix hikes for U.S. viewers since early 2014 for its most popular plan have amounted to an increase of between $1 to $2 a month in each case, but over time that's a 75% total increase.
There may very well come a time when the U.S. market will tire of feeding the meter at higher price points. No one has that kind of pricing flexibility. It just doesn't seem as if an isolated move in India would trigger price wars anywhere else in the Netflix playbook.
6
ArchPrestige
liked
$Apple (AAPL.US)$ buy when others are at fear 🥱💰😎🤘🏿
5
ArchPrestige : Don’t worry la. Just close eyes and buy